Law360, New York (October 31, 2011, 11:36 PM ET) -- A California appeals court on Monday affirmed a lower court's ruling that Bayer AG did not violate California antitrust law when it paid Barr Pharmaceuticals Inc. to delay the entry of a generic version of the antibiotic Cipro.
The appeals court denied the Cipro indirect purchasers' request to reverse the San Diego Superior Court's August 2009 summary judgment decision that tossed the suit claiming Bayer's reverse payment settlement — in which brand-name drug companies pay other companies to not make a generic version of a drug...
Calif. Court Tosses Pay-For-Delay Suit Over Bayer's Cipro
To view the full article, take a free trial now.
